Cargando…

Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier

For glioblastoma, the tumor microenvironment (TME) is pivotal to support tumor progression and therapeutic resistance. TME consists of several types of stromal, endothelial and immune cells, which are recruited by cancer stem cells (CSCs) to influence CSC phenotype and behavior. TME also promotes th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Ros, Martina, De Gregorio, Veronica, Iorio, Anna Lisa, Giunti, Laura, Guidi, Milena, de Martino, Maurizio, Genitori, Lorenzo, Sardi, Iacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213072/ https://www.ncbi.nlm.nih.gov/pubmed/30248992 http://dx.doi.org/10.3390/ijms19102879

Ejemplares similares

Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
por: Da Ros, Martina, et al.
Publicado: (2018)

Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2019)

Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
por: Iorio, Anna Lisa, et al.
Publicado: (2016)

A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
por: Giunti, Laura, et al.
Publicado: (2019)

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2017)

Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors
por: Guidi, Milena, et al.
Publicado: (2020)

Hippo Pathway in Regulating Drug Resistance of Glioblastoma
por: Casati, Giacomo, et al.
Publicado: (2021)

Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
por: Ferranti, Silvia, et al.
Publicado: (2021)

The Use of Anthracyclines for Therapy of CNS Tumors
por: da Ros, Martina, et al.
Publicado: (2015)

An infant with hyperalertness, hyperkinesis, and failure to thrive: a rare diencephalic syndrome due to hypothalamic anaplastic astrocytoma
por: Stival, Alessia, et al.
Publicado: (2015)

Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
por: Lucchesi, Maurizio, et al.
Publicado: (2018)

Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
por: Buccoliero, Anna Maria, et al.
Publicado: (2022)

Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
por: Castelli, Barbara, et al.
Publicado: (2023)

Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor
por: Modena, Piergiorgio, et al.
Publicado: (2013)

Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas
por: Masselli, Marika, et al.
Publicado: (2012)

Chemoresistance and the Self-Maintaining Tumor Microenvironment
por: Yeldag, Gulcen, et al.
Publicado: (2018)

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
por: Gaggianesi, Miriam, et al.
Publicado: (2021)

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells
por: Peña Agudelo, Jorge A., et al.
Publicado: (2023)

Novel approaches to combat chemoresistance against glioblastomas
por: Towner, Rheal A., et al.
Publicado: (2020)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
por: Souza, Leonel Cardozo de Menezes e, et al.
Publicado: (2022)

Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
por: Carvalho, Tiago M. A., et al.
Publicado: (2021)

Myeloid Cells in Glioblastoma Microenvironment
por: De Leo, Alessandra, et al.
Publicado: (2020)

Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
por: Carraro, Amedeo, et al.
Publicado: (2017)

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
por: Facchini, Ludovica, et al.
Publicado: (2017)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma
por: Lee, Derek, et al.
Publicado: (2015)

A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
por: Wang, Zihao, et al.
Publicado: (2020)

The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
por: Siebzehnrubl, Florian A, et al.
Publicado: (2013)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
por: DeCordova, Syreeta, et al.
Publicado: (2020)

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma
por: Tafani, Marco, et al.
Publicado: (2011)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
por: Hariharan, Ananya, et al.
Publicado: (2022)

Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes
por: Wang, Xian, et al.
Publicado: (2023)

The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2017)

Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance
por: Dominijanni, Anthony, et al.
Publicado: (2020)

The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia
por: Meyer, Lauren K., et al.
Publicado: (2019)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

CD8(+) T cell–Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance
por: Lao, Liyan, et al.
Publicado: (2023)

Chemoresistive Gas Sensors for the Detection of Colorectal Cancer Biomarkers
por: Malagù, Cesare, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8m5tb24qrjg8cdvov6ujm5vl3a